608
Views
9
CrossRef citations to date
0
Altmetric
Letter

Nilotinib monotherapy induced complete remission in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia resistant to imatinib and dasatinib

, , , , , & show all
Pages 1652-1653 | Received 13 May 2013, Accepted 04 Sep 2013, Published online: 01 Nov 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Michela Ansuinelli, Laura Cesini, Sabina Chiaretti & Robin Foà. (2021) Emerging tyrosine kinase inhibitors for the treatment of adult acute lymphoblastic leukemia. Expert Opinion on Emerging Drugs 26:3, pages 281-294.
Read now

Articles from other publishers (8)

Masao Hagihara, Jian Hua, Morihiro Inoue, Tomoyuki Uchida, Shiro Ide, Shin Ohara & Tomoiku Takaku. (2020) Nilotinib treatment induced large granular lymphocyte expansion and maintenance of longitudinal remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia. International Journal of Hematology 111:5, pages 719-723.
Crossref
Bingcheng Liu, Ying Wang, Chunlin Zhou, Hui Wei, Dong Lin, Wei Li, Kaiqi Liu, Guangji Zhang, Shuning Wei, Yan Li, Benfa Gong, Yuntao Liu, Xiaoyuan Gong, Yingchang Mi & Jianxiang Wang. (2019) Nilotinib combined with multi-agent chemotherapy in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia: a single-center prospective study with long-term follow-up. Annals of Hematology 98:3, pages 633-645.
Crossref
Qingbin Cui, Pranav Gupta, Lei Zhang & Zhe-Sheng Chen. 2019. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy. Protein Kinase Inhibitors as Sensitizing Agents for Chemotherapy 13 27 .
M. Aoe, H. Ishida, T. Matsubara, S. Karakawa, H. Kawaguchi, K. Fujiwara, K. Kanamitsu, K. Washio, K. Okada, M. Shibakura & A. Shimada. (2018) Simultaneous detection of ABL1 mutation and IKZF1 deletion in Philadelphia chromosome-positive acute lymphoblastic leukemia using a customized target enrichment system panel . International Journal of Laboratory Hematology 40:4, pages 427-436.
Crossref
Antonio Fasano & Adélia SequeiraAntonio Fasano & Adélia Sequeira. 2017. Hemomath. Hemomath 295 330 .
. (2016) Dasatinib/imatinib. Reactions Weekly 1601:1, pages 96-96.
Crossref
Kirsten Bleckmann & Martin Schrappe. (2016) Advances in therapy for Philadelphia-positive acute lymphoblastic leukaemia of childhood and adolescence. British Journal of Haematology 172:6, pages 855-869.
Crossref
Colleen E. Annesley & Patrick Brown. (2015) Novel agents for the treatment of childhood acute leukemia. Therapeutic Advances in Hematology 6:2, pages 61-79.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.